For example, Sgard B et al. in 2020 reported a case of pulmonary artifact on PET/CT with prostate-specific membrane antigen (PSMA) radioligands in the setting of biochemical recurrence of prostate adenocarcinoma. This evidence concerns the gene FOLH1 and prostate adenocarcinoma.